NOVARTIS-EGF30001



A Randomized, Multicenter, Double-Blind, Placebo-Controlled, 2-Arm, Phase III Study of Oral GW572016 in Combination with Paclitaxel in Subjects Previously Untreated or Advanced or Metastatic Breast Cancer
lapatinib
EGF30001
NCT00075270
Neoplasms, Breast
Phase 3
 
The raw dataset is included within the analysis-ready dataset.
June 2014